Recent advances in small airways diseases in patients with asthma and COPD
Registration for this session is additional to the congress registration fee and is: €104.5 early bird; €137.5 standard and €154 on site.
Aims : to provide an update on recent research into the increasing importance of small airways diseases in patients with asthma and COPD; to describe new developments in the assessment of small airways diseases using physiological and imaging methods; to provide an update on evidence for the clinical impact of small airways diseases on patient-related outcomes and to highlight recent data regarding treatment targeted at small airways diseases and how this relates to clinical outcomes.
Target audience :
Clinical researcher, General practitioner, Lung function technologist, Nurse, Pathologist, Physiologist, Physiotherapist, Radiologist, Student, Trainee, Adult pulmonologist/Clinician
Imaging, Physiology, Pulmonary function testing